regulatory
confidence high
sentiment negative
materiality 0.75
DNA X, Inc. (SONM): Nasdaq/NYSE listing notice — Sonim receives Nasdaq deficiency notice for low stockholders' equity of $1.334M
DNA X, Inc.
- Nasdaq notified Sonim on Aug 22, 2025 that stockholders' equity of $1.334M as of June 30, 2025 is below the $2.5M minimum for continued listing.
- Sonim also fails alternative compliance criteria (market value of listed securities $35M or net income $0.5M in recent fiscal years).
- Company has until Oct 6, 2025 to submit a compliance plan; if accepted, Nasdaq may grant up to 180 days to regain compliance.
- No immediate effect on trading of SONM common stock; Sonim is evaluating actions to regain compliance.
- No assurance that the plan will be accepted or that Sonim can regain compliance within the extension period.